These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34125957)

  • 1. A case of Philadelphia chromosome-positive acute lymphocytic leukaemia with type I CD36 deficiency.
    Matsui M; Kajiwara K; Tsukada M; Iwama K; Yamada K; Kodo H; Seto K; Tonami K; Ando M; Matsuhashi M; Watanabe-Okochi N; Tsuno NH; Kozai Y
    Vox Sang; 2022 Jan; 117(1):128-132. PubMed ID: 34125957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.
    Xu X; Ye X; Xia W; Liu J; Ding H; Deng J; Chen Y; Shao Y; Wang J; Fu Y; Santoso S
    Thromb Haemost; 2013 Dec; 110(6):1199-206. PubMed ID: 23966019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful allogeneic hematopoietic stem cell transplantation in a patient with type I CD36 deficiency: a case study and literature review.
    Okuyama S; Sumi M; Ishikawa R; Shishido T; Koyama D; Ueki T; Takahashi D; Kobayashi H; Kobayashi H; Tsuno NH
    Int J Hematol; 2023 Nov; 118(5):656-660. PubMed ID: 37490235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-center investigational study of CD36 antigen deficiency and platelet alloantibody distribution in different populations in Northern China as well as platelet alloantibodies effect on pregnancy.
    Ma C; Wang J; Yang L; Feng Y; Fu L; Guan X; Wang S; Yu Y; Wang D
    Clin Chim Acta; 2019 Nov; 498():68-75. PubMed ID: 31421121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-CD36 Mediated Platelet Transfusion Refractoriness and Related Cases After Stem Cell Transplantation].
    Zhou Y; Li LL; Zhong ZL; Liu XJ; Liu JL; Shen WD; Wu GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):541-546. PubMed ID: 29665929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
    Jabbour E; Kantarjian H; Ravandi F; Thomas D; Huang X; Faderl S; Pemmaraju N; Daver N; Garcia-Manero G; Sasaki K; Cortes J; Garris R; Yin CC; Khoury JD; Jorgensen J; Estrov Z; Bohannan Z; Konopleva M; Kadia T; Jain N; DiNardo C; Wierda W; Jeanis V; O'Brien S
    Lancet Oncol; 2015 Nov; 16(15):1547-1555. PubMed ID: 26432046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Platelet Transfusion Refractoriness in Association with Antibodies Against CD36.
    Schmidt AE; Sahai T; Refaai MA; Sullivan M; Curtis BR
    Lab Med; 2020 Sep; 51(5):540-544. PubMed ID: 31925433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrops fetalis associated with anti-CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism.
    Wu Y; Chen D; Xu X; Mai M; Ye X; Li C; Santoso S; Xia W; Fu Y
    Transfus Med; 2020 Oct; 30(5):361-368. PubMed ID: 32720360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CD36 Antigen Deficiency and Platelet Transfusion].
    Li HY; Zhou Y; Shen WD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):934-8. PubMed ID: 27342537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody.
    Xu X; Li L; Xia W; Ding H; Chen D; Liu J; Deng J; Chen Y; He Z; Wang J; Shao Y; Santoso S; Ye X; Fang Q
    Int J Hematol; 2018 Feb; 107(2):251-256. PubMed ID: 28815406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
    Lin M; Xu X; Lee HL; Liang DC; Santoso S
    Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old].
    Huang AJ; Wang LB; Du J; Tang GS; Cheng H; Gong SL; Gao L; Qiu HY; Ni X; Chen J; Chen L; Zhang WP; Wang JM; Yang JM; Hu XX
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):625-632. PubMed ID: 31495127
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports.
    Yuda J; Yamauchi N; Kuzume A; Guo YM; Sato N; Minami Y
    J Med Case Rep; 2021 Mar; 15(1):164. PubMed ID: 33762010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Daver N; Thomas D; Ravandi F; Cortes J; Garris R; Jabbour E; Garcia-Manero G; Borthakur G; Kadia T; Rytting M; Konopleva M; Kantarjian H; O'Brien S
    Haematologica; 2015 May; 100(5):653-61. PubMed ID: 25682595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness.
    Flesch BK; Scherer V; Opitz A; Ochmann O; Janson A; Steitz M; Zeiler T
    Transfusion; 2021 Jun; 61(6):1932-1942. PubMed ID: 33822386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations.
    Chen D; Wang T; Ye X; Xu X; Xia W; Fu Y
    Stem Cell Res; 2022 May; 61():102749. PubMed ID: 35305469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome.
    Khatri SS; Curtis BR; Yamada C
    Immunohematology; 2019 Dec; 35(4):139-144. PubMed ID: 31935329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of method detecting CD36 expression on human platelet and its application].
    Liu Y; Xu XG; Lan XF; Ma KR; Chen S; Hong XZ; He J; Zhu FM; Lyu HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1042-5. PubMed ID: 23998609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.